Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Cholpon Tilegenova, Ph.D
Senior Principal Scientist, Biologics Discovery at Johnson & Johnson Innovative Medicine
Speaker

Profile

Cholpon Tilegenova Ph.D. is a Senior Principal Scientist in the Biologics Discovery Department at J&J Innovative Medicine. Her focus is on multi-specific antibody design. She is a co-inventor of ProAla bispecific antibody platform leading to 3 new clinical starts. Cholpon earned her Ph.D. in Molecular Biophysics from Texas Tech University Health Sciences Center and completed postdoctoral training at Genentech, Paul Carter’s lab. Cholpon has published 8 peer reviewed papers and inventor of 3 applied patents. Cholpon travels for food and enjoys long walks.

Agenda Sessions

  • Folding-mediated Secretion of Pure Bispecific Antibodies

    , 10:20
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Cholpon at Antibody Engineering & Therapeutics Europe